BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15934088)

  • 21. Interleukin-10 gene polymorphisms are associated with the SLICC/ACR Damage Index in systemic lupus erythematosus.
    Sung YK; Park BL; Shin HD; Kim LH; Kim SY; Bae SC
    Rheumatology (Oxford); 2006 Apr; 45(4):400-4. PubMed ID: 16287924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the Fcgamma receptor IIIA-V/F158 polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis.
    Li LH; Yuan H; Pan HF; Li WX; Li XP; Ye DQ
    Scand J Rheumatol; 2010 Mar; 39(2):148-54. PubMed ID: 20059375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
    Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A
    Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p21 gene polymorphisms in systemic lupus erythematosus.
    Kong EK; Chong WP; Wong WH; Lau CS; Chan TM; Ng PK; Song YQ; Mak W; Lau YL
    Rheumatology (Oxford); 2007 Feb; 46(2):220-6. PubMed ID: 16837471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients.
    Garred P; Voss A; Madsen HO; Junker P
    Genes Immun; 2001 Dec; 2(8):442-50. PubMed ID: 11781711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.
    Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD;
    Arthritis Rheum; 2006 Oct; 55(5):799-806. PubMed ID: 17013840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal outcome and vascular morbidity in systemic lupus erythematosus (SLE): lack of association with the angiotensin-converting enzyme gene polymorphism.
    Molad Y; Gal E; Magal N; Sulkes J; Mukamel M; Weinberger A; Lalazari S; Shohat M
    Semin Arthritis Rheum; 2000 Oct; 30(2):132-7. PubMed ID: 11071585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus.
    Font J; Ramos-Casals M; Brito-Zerón P; Nardi N; Ibañez A; Suarez B; Jiménez S; Tàssies D; García-Criado A; Ros E; Sentís J; Reverter JC; Lozano F
    Rheumatology (Oxford); 2007 Jan; 46(1):76-80. PubMed ID: 16801331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of a CD24 gene polymorphism with susceptibility to systemic lupus erythematosus.
    Sánchez E; Abelson AK; Sabio JM; González-Gay MA; Ortego-Centeno N; Jiménez-Alonso J; de Ramón E; Sánchez-Román J; López-Nevot MA; Gunnarsson I; Svenungsson E; Sturfelt G; Truedsson L; Jönsen A; González-Escribano MF; Witte T; ; Alarcón-Riquelme ME; Martín J
    Arthritis Rheum; 2007 Sep; 56(9):3080-6. PubMed ID: 17763438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus.
    Guarnizo-Zuccardi P; Lopez Y; Giraldo M; Garcia N; Rodriguez L; Ramirez L; Uribe O; Garcia L; Vasquez G
    Tissue Antigens; 2007 Nov; 70(5):376-82. PubMed ID: 17711410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus.
    Svenungsson E; Gustafsson J; Leonard D; Sandling J; Gunnarsson I; Nordmark G; Jönsen A; Bengtsson AA; Sturfelt G; Rantapää-Dahlqvist S; Elvin K; Sundin U; Garnier S; Simard JF; Sigurdsson S; Padyukov L; Syvänen AC; Rönnblom L
    Ann Rheum Dis; 2010 May; 69(5):834-40. PubMed ID: 19762360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus.
    Torres B; Aguilar F; Franco E; Sánchez E; Sánchez-Román J; Jiménez Alonso J; Núñez-Roldán A; Martín J; González-Escribano MF
    Arthritis Rheum; 2004 Jul; 50(7):2211-5. PubMed ID: 15248219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of polymorphism of Fc gamma IIa receptors in Chilean patients with systemic lupus erythematosus].
    Carrión F; Figueroa F; Martínez ME; Massardo L; Pérez T; Foster C; Mancilla C; Neira O; Guzmán L; Valenzuela V; Urrutia R; Carmona S; Figueroa M; Lubiano A; Wainstein E
    Rev Med Chil; 2003 Jan; 131(1):11-8. PubMed ID: 12643213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese.
    Kong EK; Prokunina-Olsson L; Wong WH; Lau CS; Chan TM; Alarcón-Riquelme M; Lau YL
    Arthritis Rheum; 2005 Apr; 52(4):1058-62. PubMed ID: 15818672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ITGAM Arg77His is associated with disease susceptibility, arthritis, and renal symptoms in systemic lupus erythematosus patients from a sample of the Polish population.
    Warchoł T; Lianeri M; Łącki JK; Olesińska M; Jagodziński PP
    DNA Cell Biol; 2011 Jan; 30(1):33-8. PubMed ID: 20666624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
    Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M
    Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC; Ho LY; Cheung MY; Yu KL; To CH
    Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus.
    Tisseverasinghe A; Lim S; Greenwood C; Urowitz M; Gladman D; Fortin PR
    Arthritis Rheum; 2006 Jul; 54(7):2211-9. PubMed ID: 16802357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
    Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
    Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.